查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1627744

全球採血採血針市場：預測（2025-2030）

Blood lancets market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球採血採血針市場規模預計將從2025年的20.5億美元增加至2030年的30.83億美元，複合年成長率為8.50%。

採血採血針是一種小型醫療器械，用於運輸血液樣本或收集小檢體進行測試。全球糖尿病和其他感染疾病的增加正在推動預測期內的市場成長。

然而，新興國家缺乏報銷方案預計將限制未來幾年的市場擴張。

血液採血針市場促進因素：

  • 糖尿病盛行率上升推動市場成長

糖尿病盛行率的上升預計將成為預測期內市場成長的主要驅動力之一。根據2021年版第10版IDF糖尿病地圖集，2021年將有5.37億成年人（20-79歲）患有糖尿病。 2030年，全球將有6.43億糖尿病患者，到2045年，這一數字將增加至7.83億。此外，5.41 億成年人可能患有第 2 型糖尿病。此外，糖尿病日益增加的經濟負擔加上醫療支出的增加預計將增加未來幾年對血糖監測快速診斷試劑套件的需求。根據國際糖尿病聯盟（IDF）統計，2021年全球糖尿病醫療支出約9,660億美元，成長9%，直接推動市場成長。

採血採血針市場地理前景

按地區分類，採血採血針市場分為北美、南美、歐洲、中東和非洲以及亞太地區。亞太地區由中國、日本、印度和韓國等主要經濟體主導。一些成長最快的新興經濟體位於該地區，例如東南亞國協。

在亞太地區，公眾健康意識的提高以及新型血液採樣方法使用市場的快速發展正在推動未來幾年的成長。

由於老年人和目標人口數量不斷增加、研發成本不斷上升以及糖尿病治療意識不斷增強，預計北美將佔據全球採血採血針市場的大部分。此外，根據聯合國《2019年世界人口展望》數據，65歲及以上人口比例預計將從2019年的9%增加到2050年的16%以上。此外，到 2050 年，80 歲及以上的人口數量預計將增加兩倍（1.43 億對 4.26 億）。因此，隨著老年人口的增加，由於老年人更容易患慢性病，慢性病預計將變得更加普遍，從而推動採血採血針的區域市場。在歐洲，隨著人口老化日益成長的需求，國內企業正在增加併購策略投資並加劇競爭，進一步推動未來幾年的市場成長。

為什麼要購買這份報告？

  • 富有洞察力的分析：獲得涵蓋關鍵和新興地區的深入市場洞察，重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、行業和其他子區隔。
  • 競爭格局：了解世界主要企業採取的策略策略，並了解透過正確的策略滲透市場的潛力。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中釋放新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業有用且具有成本效益。

它有什麼用？

產業和市場考量、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

調查範圍

  • 2022年至2030年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 區域收益成長和預測分析，包括細分市場和國家
  • 公司簡介（主要是策略、產品、財務資訊、主要動態等）

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程
  • 資料檢驗

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析

第5章 血採血針市場：依類型

  • 介紹
  • 個人採血採血針
  • 安全採血採血針

第6章 採血採血針市場：依應用分類

  • 介紹
  • 血糖測試
  • 血紅素測試
  • 其他用途

第7章 血採血針市場：依最終用戶分類

  • 介紹
  • 醫院/診所
  • 血庫
  • 居家照護
  • 其他

第8章 血採血針市場：依地區

  • 世界概況
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東/非洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他亞太地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 新興企業和市場盈利
  • 併購/協議/合作
  • 競爭對手儀表板

第10章 公司簡介

  • Becton, Dickinson, and Company
  • B. Braun Melsungen AG
  • Terumo Europe NV
  • Owen Mumford Ltd
  • Messe Dusseldorf GmbH
  • SteriLance Medical（Suzhou）Inc
  • Medline Industries, Inc
  • FL Medical SRL
簡介目錄
Product Code: KSI061613504

The blood lancets market is estimated to grow at a CAGR of 8.50% to reach a market size of US$3.083 billion in 2030 from US$2.050 billion in 2025.

Blood lancets are small medical implements for carrying blood samples or obtaining small specimens for testing. The increasing prevalence of diabetes and other infectious diseases worldwide is driving market growth during the forecast period.

However, the lack of reimbursement scenarios in developing countries is anticipated to restrain the market expansion in the coming years.

Blood lancets market drivers:

  • The rising prevalence of diabetes is driving the growth of the market

The rising prevalence of diabetes is expected to be one of the prime drivers of the market's growth during the forecast period. According to the IDF Diabetes Atlas' tenth edition for 2021, 537 million adults (20-79 years old) had diabetes in 2021. By 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. Additionally, type 2 diabetes is more likely to occur in 541 million adults. In addition, the rising economic burden of diabetes coupled with increasing healthcare expenditure worldwide is also anticipated to increase the demand for rapid diagnostic kits for glucose monitoring in the coming years. According to the International Diabetes Federation (IDF), global healthcare expenditure on diabetes was around US$966 billion in 2021, representing a growth of 9%, directly fueling the market's growth.

Blood lancets market geographical outlook:

By geography, the blood lancets market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The major economies like China, Japan, India, and South Korea dominate the Asia-Pacific region. Some of the fastest-growing emerging economies are from this region, such as ASEAN countries.

In the Asia Pacific region, increasing health awareness among the population coupled with the rapid market evolution in using new types of blood sampling methods is propelling its growth in the coming years.

North America is anticipated to dominate a large portion of the global blood lancet market because of its growing elderly and targeted populations, increasing R&D costs, and rising diabetes treatment awareness. In addition, the percentage of individuals over 65 is expected to rise from 9 percent in 2019 to more than 16 percent in 2050, according to figures from the United Nations' World Population Prospects in 2019. In addition, it is expected that by 2050, there will be three times as many people aged 80 or older population (143 million vs. 426 million). As a result, as the elderly population grows, chronic diseases are predicted to become more prevalent because older people are more likely to develop them, propelling the regional market for blood lancets. In Europe, domestic players are increasing strategic investment in mergers and acquisitions, increasing the competition and further propelling market growth in the coming years to address the growing needs of the region's aging population.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The blood lancets market is analyzed into the following segments:

By Type

  • Personal Blood lancets
  • Safety Blood lancets

By Application

  • Glucose Testing
  • Hemoglobin Testing
  • Other application

By End User

  • Hospitals &Clinics
  • Blood Banks
  • Homecare
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Rest of the Middle East and Africa
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Rest of Asia-Pacific

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process
  • 2.3. Data Validation

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Supplier
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. BLOOD LANCETS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Personal Blood lancets
  • 5.3. Safety Blood lancets

6. BLOOD LANCETS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Glucose Testing
  • 6.3. Hemoglobin Testing
  • 6.4. Other application

7. BLOOD LANCETS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals &Clinics
  • 7.3. Blood Banks
  • 7.4. Homecare
  • 7.5. Others

8. BLOOD LANCETS MARKET BY GEOGRAPHY

  • 8.1. Global Overview
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Rest of South America
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Rest of Europe
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. United Arab Emirates
    • 8.5.3. Rest of the Middle East and Africa
  • 8.6. Asia-Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Rest of Asia-Pacific

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Becton, Dickinson, and Company
  • 10.2. B. Braun Melsungen AG
  • 10.3. Terumo Europe NV
  • 10.4. Owen Mumford Ltd
  • 10.5. Messe Dusseldorf GmbH
  • 10.6. SteriLance Medical (Suzhou) Inc
  • 10.7. Medline Industries, Inc
  • 10.8. F.L. Medical SRL